Medicine professor slams SA Ivermectin sceptics; many experts aren’t looking at the right data

Loading player...
A black market in Ivermectin has developed, with many South Africans opting for veterinary versions to ward off and stop Covid-19 from developing. Professor Colleen Aldous, a healthcare scientist at the University of KwaZulu-Natal’s School of Medicine says there is compelling evidence that Ivermectin shows good promise in curing people infected with the coronavirus. Instead of obsessing about human trials to test Covid-19, scientists need to look at the other ways of assessing medicine for use under emergency conditions. She criticises some of the biggest names in SA science circle for having their blinkers on. She spoke to Jackie Cameron of BizNews, about how she moved from being an Ivermectin sceptic to a disciple. The regulatory authority in SA has approved limited use of Ivermectin, but some doctors have complained that their applications for the compassionate use of the drug have not been approved. The South African Health Products Regulatory Authority is reported as telling Parliament that there is not enough evidence on the use of the drug - its safety and efficacy - to treat or prevent Covid-19. Learn more about your ad choices. Visit megaphone.fm/adchoices
18 Feb 2021 9AM English South Africa Investing · Business News

Other recent episodes

Solly Moeng on Ramaphosa, his shadowy advisers and a fading legacy

In their weekly chat Chris Steyn and political commentator Solly Moeng dissect President Cyril Ramaphosa’s tough week on several fronts: The Madlanga Commission of Inquiry is seeking answers from his very influential former adviser, Dr Bejani Chauke, particularly in relation to WhatsApp chats with a notorious late taxi boss; his…
29 Oct 10AM 21 min

Gareth van Onselen on the metro races that could redraw SA politics

Six days before the vote, four serious pollsters could not agree on who was winning Johannesburg. Gareth van Onselen, whose Victory Research polls have drawn fire from the ANC and ActionSA alike, told Alec Hogg why the metro numbers diverged, why turnout could swing a party by up to five…
29 Oct 8AM 44 min

Donald MacKay: Find the JSE guilty - or not - and move on

In this interview with Chris Steyn, Donald MacKay, the CEO of XA Global Trade Advisors, describes how anti-competitive behaviour is rewarded when investigations drag on. He was speaking out amid a long wait to find out whether the Johannesburg Stock Exchange (JSE) will be hit with a penalty of ten…
29 Oct 5AM 10 min